Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A genetically heterogeneous group of neuronal ceroid lipofuscinoses (NCLs) typically characterized by onset during infancy or early childhood with decline of mental and motor capacities, epilepsy, and vision loss through retinal degeneration.
Biomarker and diagnostic research for late infantile neuronal ceroid lipofuscinosis has been reported in the published literature.
4 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, other interventions, and medical devices. Pipeline includes 1 PHASE1. Research is sponsored by a mix of industry and academic institutions.
15 publications have been identified in PubMed for late infantile neuronal ceroid lipofuscinosis. Research spans Case Report / Case Series (33%), Basic Science / Preclinical (20%), and Other (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 5 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 2:38 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research | 3 | 20% |
Other research | 2 | 13% |
Testing and diagnosis research | 2 | 13% |
Disease patterns and progression | 2 | 13% |
New treatment approaches | 1 | 7% |
Simonati A (2026). [PMID: 40708162](https://pubmed.ncbi.nlm.nih.gov/40708162/). *Dev Med Child Neurol*. [Epidemiology / Natural History]
Walus M (2026). [PMID: 42102651](https://pubmed.ncbi.nlm.nih.gov/42102651/). *Mol Genet Metab*. [Basic Science / Preclinical]
Auvin S (2026). [PMID: 41354011](https://pubmed.ncbi.nlm.nih.gov/41354011/). *Eur J Paediatr Neurol*. [Epidemiology / Natural History]
Datta AN (2025). [PMID: 40865184](https://pubmed.ncbi.nlm.nih.gov/40865184/). *Seizure*. [Case Report / Case Series]
Chaoul V (2025). [PMID: 40358187](https://pubmed.ncbi.nlm.nih.gov/40358187/). *Cells*. [Basic Science / Preclinical]
Bauchat A (2025). [PMID: 39471475](https://pubmed.ncbi.nlm.nih.gov/39471475/). *Stem Cells Transl Med*. [Case Report / Case Series]
Rogers DL (2025). [PMID: 40578219](https://pubmed.ncbi.nlm.nih.gov/40578219/). *Pediatr Neurol*. [Gene Therapy / Novel Therapeutics]
Bryzik A (2025). [PMID: 40686560](https://pubmed.ncbi.nlm.nih.gov/40686560/). *Front Genet*. [Case Report / Case Series]
Kose S (2024). [PMID: 39362589](https://pubmed.ncbi.nlm.nih.gov/39362589/). *Life Sci*. [Basic Science / Preclinical]
Nicolaou P (2024). [PMID: 38988832](https://pubmed.ncbi.nlm.nih.gov/38988832/). *Front Genet*. [Other]